PET (Positron Emission Tomography) Market Research Reports & Industry Analysis
PET measures the metabolic activity of cells in the human body. It provides valuable information on the biochemical and biological activity inside a living subject in a non-invasive way, combining techniques that are applied in nuclear medicine with the precise localization that is achieved by computerized image reconstruction.
As a biological imaging examination, PET can detect and stage tumors, often before they are visible through other conventional examinations. In addition, PET can provide doctors with important early information about heart disease or several neurological disorders such as Alzheimer’s, Parkinson’s, epilepsy and dementia. Biochemical processes change with disease and may be altered before there is a change in gross anatomy. PET is able to detect extremely small cancers and very subtle changes of function in the brain and heart, due to disease-related modifications in tissue perfusion or cell metabolic rates.
PET (Positron Emission Tomography) Industry Research & Market Reports
-
Brain PET-MRI Systems Market by Phase (Clinical, Pre-Clinical), Product (Helium-Free PET/MRI System, Traditional PET/MRI System), End-User - Global Forecast 2024-2030
... expected to reach USD 4.19 billion in 2024, at a CAGR 12.83% to reach USD 8.65 billion by 2030. Global Brain PET-MRI Systems Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Artificial Intelligence in Medical Imaging Market by Offering (Services, Software Tools/Platform), Image Acquisition Technology (Computed Tomography, Magnetic Resonance Imaging, Molecular Imaging), Application, End-user - Global Forecast 2024-2030
... was estimated at USD 1.24 billion in 2023 and expected to reach USD 1.57 billion in 2024, at a CAGR 26.87% to reach USD 6.57 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
Global Positron Emission Tomography (PET) Market Research Report 2024(Status and Outlook)
... is a nuclear medicine functional imaging technique that is used to observe metabolic processes in the body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer), which is introduced into ... Read More
-
Neuroimaging Market, By Technology (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Functional Magnetic Resonance Imaging (fMRI), Diffusion Tensor Imaging (DTI), Magnetoencephalography (MEG), Electroencephalography (EEG), and Others), By Application (Neurological Disorders, Psychiatric Disorders, Traumatic Brain Injury), By End User (Hospitals and Clinics, Diagnostic Centers, Research Institutes, Ambulatory Surgical Centers, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East)
... Others), By Application (Neurological Disorders, Psychiatric Disorders, Traumatic Brain Injury), By End User (Hospitals and Clinics, Diagnostic Centers, Research Institutes, Ambulatory Surgical Centers, and Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle ... Read More
-
Positron Emission Tomography Market Forecasts to 2030 – Global Analysis By Product (Radiotracers, Positron Emission Tomography (PET) Scanners, Radiopharmaceuticals and Other Products), Application, End User and By Geography
... Emission Tomography Market is accounted for $1.5 billion in 2023 and is expected to reach $2.7 billion by 2030 growing at a CAGR of 8.6% during the forecast period. A nuclear medicine and biochemical analysis ... Read More
-
Global Positron Emission Tomography Market 2024-2028
... positron emission tomography market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
South & Central America Radiopharmaceutical Theranostics Market Forecast to 2028 - Regional Analysis - by Product Type (Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers), Radioisotope (Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others); Source (Nuclear Reactors and Cyclotrons), Application (Targeted Therapeutic [Rx] and Companion Diagnostic [CDx]); Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
... 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others); Source (Nuclear Reactors and Cyclotrons), Application (Targeted Therapeutic [Rx] and Companion Diagnostic [CDx]); Indication (Oncology, Cardiology, Neurology, and Others), and End User ... Read More
-
Middle East & Africa Radiopharmaceutical Theranostics Market Forecast to 2028 - Regional Analysis - by Product Type (Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers), Radioisotope (Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others); Source (Nuclear Reactors and Cyclotrons), Application (Targeted Therapeutic [Rx] and Companion Diagnostic [CDx]); Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
... 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others); Source (Nuclear Reactors and Cyclotrons), Application (Targeted Therapeutic [Rx] and Companion Diagnostic [CDx]); Indication (Oncology, Cardiology, Neurology, and Others), and End User ... Read More
-
Brain and Neuroimaging Devices Market Forecasts to 2030 – Global Analysis By Imaging Type (Computed Tomography, Functional Magnetic Resonance Imaging, Positron Emission Tomography, Electroencephalography, Near Infrared Spectroscopy, Magneto encephalography, Intracranial Pressure Monitors, Cerebral Oximeters, Sleep Monitoring Devices, Electromyography Devices and Other Imaging Types ), Procedure (Invasive and Non-Invasive ), Application, End User and By Geography
... Monitoring Devices, Electromyography Devices and Other Imaging Types ), Procedure (Invasive and Non-Invasive ), Application, End User and By Geography According to Stratistics MRC, the Global Brain and Neuroimaging Devices Market is accounted for $22.4 ... Read More
-
Hybrid Imaging Market Forecasts to 2030 – Global Analysis By Type (Positron Emission Tomography & Computed Tomography (PET-CT) Scan, Single-Photon Emission Computed Tomography (SPECT) Scan, Optical Coherence Tomography (OCT), Fundus Imaging System and Other Types), Technology, Application, End User and By Geography
... Technology, Application, End User and By Geography According to Stratistics MRC, the Global Hybrid Imaging Market is accounted for $8.63 billion in 2023 and is expected to reach $13.33 billion by 2030 growing at a ... Read More
-
Artificial Intelligence in Medical Imaging Market Forecasts to 2030 – Global Analysis By Offering (Software Tools/Platform, and Services), Modality (X-ray, Magnetic Resonance Imaging (MRI), Ultrasound imaging, Computed tomography (CT) and Molecular imaging), Technology (Deep Learning, Computer Vision, Natural Language Processing (NLP) and Other Technologies), Application, End User and By Geography
... Computer Vision, Natural Language Processing (NLP) and Other Technologies), Application, End User and By Geography According to Stratistics MRC, the Global Artificial Intelligence in Medical Imaging Market is accounted for $1,001.1 million in 2023 and ... Read More
-
Cognitive Neuroscience Market Forecasts to 2030 – Global Analysis By Type (Functional Magnetic Resonance Imaging (fMRI), Encephalography (EEC), Near Infrared Spectroscopy (NIRS), Magnetic Resonance Imaging (MRI), Magnetoencephalography (MEG), Single Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and Other Types), Component, Application and By Geography
... Emission Tomography (PET), and Other Types), Component, Application and By Geography According to Stratistics MRC, the Global Cognitive Neuroscience Market is accounted for $36.72 billion in 2023 and is expected to reach $62.93 billion by ... Read More
-
Brain Mapping Instruments Market Forecasts to 2030 – Global Analysis By Product Type (Magnetic Resonance Imaging (MRI), Near-Infrared Spectroscopy (NIRS), Electroencephalography (EEG), Positron Emission Tomography (PET), Computed Tomography and Other Product Types), End User and By Geography
... By Geography According to Stratistics MRC, the Global Brain Mapping Instruments Market is accounted for $2.5 billion in 2023 and is expected to reach $4.2 billion by 2030 growing at a CAGR of 8.1% during ... Read More
-
Multiple Myeloma Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Smoldering (indolent) Multiple Myeloma, Active (Symptomatic) Multiple Myeloma); By Treatment (Chemotherapy, Targeted Therapy, Immunomodulatory Drugs, Steroids, Bone-Modifying Drugs, Immunotherapy, Bone Marrow/Stem Cell Transplantation, Radiation Therapy, Surgery); By Diagnosis (Blood & Urine Tests, X-ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT/CAT) Scan, Positron Emission Tomography (PET)/ PET-CT Scan, Bone Marrow Aspiration & Biopsy, Fat Pad Aspirate, Biomarker Testing of the Tumor); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
... Immunotherapy, Bone Marrow/Stem Cell Transplantation, Radiation Therapy, Surgery); By Diagnosis (Blood & Urine Tests, X-ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT/CAT) Scan, Positron Emission Tomography (PET)/ PET-CT Scan, Bone Marrow Aspiration & Biopsy, Fat ... Read More
-
AI in Medical Imaging Market By Modality (CT Scan, MRI, X-rays, Ultrasound Imaging, Molecular Imaging), By Technology (Deep Learning, Natural Language Processing (NLP), Computer Vision, Others), By Application (Breast Imaging, Respiratory and Pulmonary, Neurology, Orthopedics, Others), By Industry Vertical (Hospital and Healthcare Providers, Patients, Pharmaceuticals and Biotechnology Companies, Healthcare Payers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
... Others), By Industry Vertical (Hospital and Healthcare Providers, Patients, Pharmaceuticals and Biotechnology Companies, Healthcare Payers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032 The AI in medical imaging market size was valued at $1,891.12 million ... Read More
-
Radiopharmaceutical Theranostics Global Market Report 2023 Including: 1) By Product Type: Alpha Emitters; Beta Emitters; Positron Emission Tomography (PET) Tracers 2) By Source: Nuclear Reactors; Cyclotrons 3) By Radioisotope: Technetium-99; Gallium-68; Iodine-131; Iodine-123; 18F; Y-90; Lutetium (Lu) 177; Copper (Cu) 67; Copper (Cu) 64 4) By Indication: Oncology; Cardiology; Neurology 5) By End User: Hospitals; Diagnostic Imaging Centers; Academic And Research Institutesrs Covering: Cardinal Health Inc.; AstraZeneca Plc; GE HealthCare Technologies Inc.; Bayer AG; China Grand Pharmaceutical & Healthcare.
... 177; Copper (Cu) 67; Copper (Cu) 644) By Indication: Oncology; Cardiology; Neurology5) By End User: Hospitals; Diagnostic Imaging Centers; Academic And Research InstitutesrsCovering: Cardinal Health Inc.; AstraZeneca Plc; GE HealthCare Technologies Inc.; Bayer AG; China ... Read More
-
Multimodal Imaging Market by Technology (PET-CT, SPECT-CT, PET-MR, OCT/FMT), Application (Oncology, Cardiology, Brain, Ophthalmology), End User (Hospitals, Diagnostic Centers, Academia, Research) & Region - Global Forecast to 2028
... reach USD 5.5 billion by 2028 from USD 4.2 billion in 2023, at a CAGR of 5.7% from 2023 to 2028. Factors such as the high incidence/prevalence of target diseases, the growing number of diagnostic ... Read More
-
North America Clinical Trial Imaging Market Forecast to 2028 -Regional Analysis - by Modality [Tomography, Magnetic Resonance Imaging (MRI), Ultrasound, Positron Emission Tomography (PET), X-Ray, Echocardiography, and Others], Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others]
... Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others] The North America clinical trial imaging market is expected to grow ... Read More
-
South America Clinical Trial Imaging Market Forecast to 2028 -Regional Analysis - by Modality [Tomography, Magnetic Resonance Imaging (MRI), Ultrasound, Positron Emission Tomography (PET), X-Ray, Echocardiography, and Others], Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others]
... Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others] The South America clinical trial imaging market is expected to grow ... Read More
-
Global Positron Emission Tomography and Computed Tomography Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
... size was valued at USD 1544.5 million in 2022 and is forecast to a readjusted size of USD 3903.6 million by 2029 with a CAGR of 14.2% during review period. The influence of COVID-19 and ... Read More
-
Global Positron Emission Tomography and Computed Tomography Supply, Demand and Key Producers, 2023-2029
... market growth of 14.2% CAGR during the forecast period (2023-2029). Positron Emission Tomography and Computed Tomography (PET/CT for short) is a high-end medical device for functional and anatomical imaging of the human body and its ... Read More
-
Positron Emission Tomography System Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type
... 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price ... Read More
-
Middle East & Africa Clinical Trial Imaging Market Forecast to 2028 -Regional Analysis - by Modality [Tomography, Magnetic Resonance Imaging (MRI), Ultrasound, Positron Emission Tomography (PET), X-Ray, Echocardiography, and Others], Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others]
... Analysis Services, Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others] The Middle East & Africa clinical trial imaging market ... Read More
-
Europe Clinical Trial Imaging Market Forecast to 2028 -Regional Analysis - by Modality [Tomography, Magnetic Resonance Imaging (MRI), Ultrasound, Positron Emission Tomography (PET), X-Ray, Echocardiography, and Others], Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others]
... Design and Consulting Services, and Others), and End User [Contract Research Organizations (CROs), Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Others] The Europe clinical trial imaging market is expected to grow from US$ ... Read More
-
Europe Radiopharmaceutical Theranostics Market Forecast to 2028 -Regional Analysis - by Product Type [Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers], Radioisotope [Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
... (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and ... Read More
Research Assistance
